These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis. Heuer L; Petry G; Pollmeier M; Schaper R; Deuster K; Schmidt H; Blazejak K; Strube C; Di Cesare A; Traversa D; Schnyder M; McKay-Demeler J; von Samson-Himmelstjerna G; Mangold-Gehring S; Böhm C Parasit Vectors; 2020 Feb; 13(1):65. PubMed ID: 32051008 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of a spot-on formulation containing 280 mg/ml fluralaner and 14 mg/ml moxidectin (Bravecto® Plus) in the prevention of cat aelurostrongylosis under field conditions. Di Cesare A; Morelli S; Rohdich N; Kirkova Z; Capári B; Loehlein W; Wolf O; Zschiesche E; Colombo M; Astuti C; Traversa D Vet Parasitol; 2024 Apr; 327():110114. PubMed ID: 38286060 [TBL] [Abstract][Full Text] [Related]
5. Shedding of feline lungworm larvae and their infectivity to snail intermediate hosts after anthelmintic treatment. Cavalera MA; Colella V; Napoli E; Arfuso F; Panarese R; Brianti E; Otranto D Int J Parasitol; 2019 May; 49(6):449-453. PubMed ID: 30904621 [TBL] [Abstract][Full Text] [Related]
6. A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus). Rohdich N; Zschiesche E; Wolf O; Loehlein W; Kirkova Z; Iliev P; Rapti D; Postoli R; Capári B; Farkas R; Roepke RKA Parasit Vectors; 2018 Nov; 11(1):589. PubMed ID: 30449275 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate Diakou A; Morelli S; Dimzas D; Di Cesare A; Capelli G; Parrinello C; Pollmeier M; Schaper R; Traversa D Parasit Vectors; 2019 Nov; 12(1):519. PubMed ID: 31685011 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis. Traversa D; Di Cesare A; Milillo P; Lohr B; Iorio R; Pampurini F; Schaper R; Paoletti B; Heine J Parasitol Res; 2009 Aug; 105 Suppl 1():S55-62. PubMed ID: 19575226 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of a parasiticide formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard® Combo) in the treatment of natural feline aelurostrongylosis and troglostrongylosis. Di Cesare A; Veronesi F; Crisi PE; Colombo M; Morelli S; Vignoli M; Rigamonti G; Iorio R; Tielemans E; Beugnet F; Gamblin C; Traversa D Vet Parasitol; 2024 Oct; 331():110271. PubMed ID: 39089177 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats. Taenzler J; de Vos C; Roepke RKA; Heckeroth AR Parasit Vectors; 2018 Nov; 11(1):595. PubMed ID: 30449272 [TBL] [Abstract][Full Text] [Related]
11. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats. Rohdich N; Zschiesche E; Wolf O; Loehlein W; Pobel T; Gil MJ; Roepke RKA Parasit Vectors; 2018 Nov; 11(1):598. PubMed ID: 30454052 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Broadline® spot-on against Aelurostrongylus abstrusus and Troglostrongylus brevior lungworms in naturally infected cats from Italy. Giannelli A; Brianti E; Varcasia A; Colella V; Tamponi C; Di Paola G; Knaus M; Halos L; Beugnet F; Otranto D Vet Parasitol; 2015 Apr; 209(3-4):273-7. PubMed ID: 25819917 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Emodepside/Praziquantel Spot-on (Profender®) against adult Aelurostrongylus abstrusus Nematodes in Experimentally Infected Cats. Böhm C; Wolken S; Schnyder M; Basso W; Deplazes P; Di Cesare A; Deuster K; Schaper R Parasitol Res; 2015 Aug; 114 Suppl 1():S155-64. PubMed ID: 26152416 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto Fisara P; Guerino F; Sun F Parasit Vectors; 2019 May; 12(1):259. PubMed ID: 31122282 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of a novel topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel against larval and adult stages of the cat lungworm, Aelurostrongylus abstrusus. Knaus M; Chester ST; Rosentel J; Kühnert A; Rehbein S Vet Parasitol; 2014 Apr; 202(1-2):64-8. PubMed ID: 24703080 [TBL] [Abstract][Full Text] [Related]
16. Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats. Walther FM; Fisara P; Roepke RKA Parasit Vectors; 2018 Nov; 11(1):597. PubMed ID: 30454033 [TBL] [Abstract][Full Text] [Related]
17. Detection of specific antibodies in cats infected with the lung nematode Aelurostrongylus abstrusus. Zottler EM; Strube C; Schnyder M Vet Parasitol; 2017 Feb; 235():75-82. PubMed ID: 28215872 [TBL] [Abstract][Full Text] [Related]
18. Clinical, laboratory and pathological findings in cats experimentally infected with Aelurostrongylus abstrusus. Schnyder M; Di Cesare A; Basso W; Guscetti F; Riond B; Glaus T; Crisi P; Deplazes P Parasitol Res; 2014 Apr; 113(4):1425-33. PubMed ID: 24504600 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats. Traversa D; Raue K; Ringeisen H; Blazejak K; Bisterfeld K; Di Cesare A; Colombo M; Böhm C; Strube C; Pollmeier M Parasit Vectors; 2022 Feb; 15(1):66. PubMed ID: 35193656 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of emodepside 2.1%/praziquantel 8.6% spot-on formulation in the treatment of feline aelurostrongylosis. Traversa D; Milillo P; Di Cesare A; Lohr B; Iorio R; Pampurini F; Schaper R; Bartolini R; Heine J Parasitol Res; 2009 Aug; 105 Suppl 1():S83-9. PubMed ID: 19575229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]